» Articles » PMID: 35619217

Coronavirus Disease 2019 Transmission and Symptoms in Young Children During the Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant and Omicron Variant Outbreaks

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2022 May 27
PMID 35619217
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Little is known about the transmission of coronavirus disease 2019 (COVID-19) in young children. This study aimed to clarify the risk of COVID-19 transmission among this population.

Methods: Between July 2020 and April 2022, 1660 0 to 3-year-old children underwent a nasopharyngeal swab for later reverse transcription-polymerase chain reaction testing at a mass screening test center in Japan. Their disease transmission rate and clinical symptoms were evaluated according to the predominant variant strains of that season.

Results: The secondary transmission rate after close contact of the Delta B.1.617.2 (17.4%) and Omicron B.1.1.529 (39.2%) variants was significantly higher than that of the conventional strains (B.1.1.284 and B.1.1.214; 4.5%) during the pandemic. The increased transmissibility with the Delta and Omicron variants was independent of close contact or location. The prevalence rates of cough, fatigability, and fever were similar in young children infected by the Delta and Omicron variants.

Conclusions: COVID-19 transmission in children aged 0 to 3 years increased by 3 to 4 fold during the Delta outbreak and by 8 to 10 fold during the Omicron outbreak compared with the conventional strain outbreak. The symptoms in young children were not different between the Delta and Omicron variants.

Citing Articles

Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review.

Weber D, Zimmerman K, Tartof S, McLaughlin J, Pather S Vaccines (Basel). 2024; 12(9).

PMID: 39340021 PMC: 11435672. DOI: 10.3390/vaccines12090989.


miR-29 as diagnostic biomarkers for tuberculosis: a systematic review and meta-analysis.

He J, Xiong J, Huang Y Front Public Health. 2024; 12:1384510.

PMID: 38807999 PMC: 11130415. DOI: 10.3389/fpubh.2024.1384510.


Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence.

SeyedAlinaghi S, Afsahi A, Mirzapour P, Afzalian A, Shahidi R, Dashti M Infect Disord Drug Targets. 2024; 24(7):e050324227686.

PMID: 38445691 DOI: 10.2174/0118715265279242240216114548.


Antibodies against SARS-CoV-2 in unvaccinated children hospitalized with COVID-19: An observational cohort study of pre-Omicron and Omicron variants era.

Uppala R, Sitthikarnkha P, Faksri K, Kosalaraksa P, Techasatian L, Tantawarak N PLoS One. 2024; 19(2):e0297991.

PMID: 38394318 PMC: 10890774. DOI: 10.1371/journal.pone.0297991.


Parents' attitudes toward childhood COVID-19 immunization in Croatia: a multicenter cross-sectional study.

Sasic M, Bodulic K, Hojsak I, Masic M, Trivic I, Markic J Croat Med J. 2023; 64(1):52-60.

PMID: 36864819 PMC: 10028565.


References
1.
Song P, Karako T . The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022. Biosci Trends. 2022; 15(6):350-352. DOI: 10.5582/bst.2021.01560. View

2.
Torjesen I . Covid-19: Omicron variant is linked to steep rise in hospital admissions of very young children. BMJ. 2022; 376:o110. DOI: 10.1136/bmj.o110. View

3.
Ludvigsson J . Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109(6):1088-1095. PMC: 7228328. DOI: 10.1111/apa.15270. View

4.
Panahi L, Amiri M, Pouy S . Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review. Arch Acad Emerg Med. 2020; 8(1):e50. PMC: 7212072. View

5.
Shirato K, Nao N, Katano H, Takayama I, Saito S, Kato F . Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan. Jpn J Infect Dis. 2020; 73(4):304-307. DOI: 10.7883/yoken.JJID.2020.061. View